Jacobio's induced-allosteric drug discovery platform identifies cryptic allosteric binding sites and converts them into inhibitor programs against undruggable targets.

Jacobio Pharma
Jacobio Pharma is a biopharmaceutical company developing targeted cancer therapies against historically undruggable signaling proteins.
- 300
- Public company
- Beijing, CNChina
Jacobio Pharma discovers and develops small-molecule, antibody, and antibody-drug conjugate therapies that target oncogenic signaling pathways, including RAS, P53, RB, MYC, immune checkpoints, and tumor metabolism. Its discovery work is anchored by an induced-allosteric drug discovery platform and an immune-stimulating antibody-drug conjugate platform.
Its KRAS G12C inhibitor glecirasib is approved in China for previously treated KRAS G12C-mutated non-small cell lung cancer and is included in China's National Reimbursement Drug List. The company has out-licensed pipeline programs to partners including AbbVie, AstraZeneca, and Allist, and it conducts clinical combination studies with Merck.
Products & Services
Similar Companies

Pendulum Therapeutics

Relay Therapeutics
relaytx.com

HotSpot Therapeutics
hotspotthera.com

Gain Therapeutics

Allorion Therapeutics
alloriontx.com

Quanta Therapeutics
quantatx.com

Beactica Therapeutics
beactica.com

InnoCare Pharma
innocarepharma.com

Arvinas
arvinas.com

Revere Pharmaceuticals
reverepharma.com

Jubilant Biosys
jubilantbiosys.com

Immuneering
immuneering.com

Incyte
incyte.com

Circle Pharma
circlepharma.com

Kestrel Therapeutics
KinoDyn

Alloy Therapeutics
alloytx.com

Bristol Myers Squibb
bms.com

AskGene Pharma
ask-gene.com

Dracen Pharmaceuticals
dracenpharma.com
Quick Facts
Who are Jacobio Pharma's competitors?
Companies similar to Jacobio Pharma include Relay Therapeutics, HotSpot Therapeutics, Gain Therapeutics and Allorion Therapeutics.
When was Jacobio Pharma founded?
Jacobio Pharma was founded in 2015.
Where is Jacobio Pharma's headquarters located?
Jacobio Pharma's headquarters is located in Beijing, CN.
When was Jacobio Pharma's last funding round?
Jacobio Pharma's most recent funding round was for CN¥150M (CNY) in January 2023.
How much disclosed funding has Jacobio Pharma raised?
As of Jan 1, 2023, Jacobio Pharma has disclosed funding of $296.3M (USD). Undisclosed round amounts are excluded.
How many employees does Jacobio Pharma have?
Jacobio Pharma has 300 employees as of Sep 14, 2026.
Classification
- Revenue
- Customer
- Tags
- Also Known As
- Jacobio Pharmaceuticals Group Co., Ltd.
- Jacobio Pharmaceuticals
- Jacobi Biopharma
- 加科思药业集团
- Headquarters
- Building 8, No.105 Jinghai 3rd Road, BDA
- Beijing, Beijing, 101111
- CN
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8730Research, Development, And Testing Services
- 8731Commercial Physical and Biological Research
- Industry
- —Biotechnology Companies
- —Health Care Companies
- —Medical Organizations
- —Pharmaceutical Companies
Show 13 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 623000Nursing and Residential Care Facilities
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 2800Chemicals And Allied Products
- 8000Health Services
- 2830Drugs
- 8040Offices And Clinics Of Other Health Practitioners
- 2834Pharmaceutical Preparations
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified